ALKBH5 and plasmacytoma: Despite ALKBH5 has been identified to contribute significantly to physiological osteogenesis (Yu et al., 2020), ALKBH5 mediates osteosarcoma (OS) tumorigenesis via demethylation of plasmacytoma variant translocation one, a tumorigenic lncRNA.